Advancing Innovative Therapies for Patients Worldwide.

Our Story

At Kaizhi Biotherapeutics, we translate science into therapies that matter.

Our Capabilities

Focused on translational science, clinical development, and strategic partnerships.

Translational Science

Integrating disease biology with clinically relevant research to enable efficient program advancement

Clinical Development

Designing and executing biomarker-driven clinical strategies with a focus on early proof-of-concept

Partnering with academic institutions and global biopharma to accelerate development timelines

Strategic Collaboration

Our Therapeutic Areas

We focus our expertise where the unmet need is greatest. Our discovery and development programs are concentrated in oncology and immunology — two interconnected fields where emerging science is opening entirely new therapeutic possibilities. Kaizhi is committed to advancing its pipeline through global clinical development and strategic partnerships across Asia, Europe, and North America.

Oncology

Oncology programs focus on solid tumors and hematological malignancies with high unmet medical need. Key areas of focus include non-small cell lung cancer (NSCLC), gastric cancer, and selected hematological malignancies.Our approach emphasizes,

1. Targeted pathway modulation

2. Tumor microenvironment interaction

3. Resistance mechanism analysis

4. Biomarker-guided patient selection

Immunology

Immunology programs are focused on the modulation of immune pathways involved in autoimmune and inflammatory diseases.

Key focus areas include rheumatoid arthritis and inflammatory bowel disease, where dysregulated immune responses drive chronic disease burden.